封面
市场调查报告书
商品编码
1401768

非处方药市场,按类型、配销通路、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

OTC Drugs Market, By Type, By Distribution channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日期: | 出版商: AnalystView Market Insights | 英文 297 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年非处方药市场规模为 1,627.943 亿美元,2023 年至 2030 年复合CAGR为 5.0%。

非处方药市场-市场动态

製造商从处方分销管道转向非处方药预计将推动市场需求

市场的突出趋势之一是製造商从处方分销管道转向非处方药。许多製造公司正在将其产品从处方药转向非处方药。例如,拜耳公司在2019年年报中表示,作为其策略的一部分,该公司将把部分适合自我照护的处方产品改为非处方药。预计这将导致新兴国家和已开发国家针对各种疾病的这些分销管道的可用性更高。市场的其他趋势包括自有品牌非处方药产品数量的增加。非处方药产品在线销售的成长以及自有品牌製造商和电子商务公司之间的合作正在形成市场新趋势。例如,2019年9月,Dr. Reddy's Laboratories Ltd.宣布在美国市场推出非处方药奥美拉唑缓释片。这些即将到来的新趋势将使预测期内的市场成长多样化。

非处方药市场 - 关键见解

根据我们的研究分析师分享的分析,全球非处方药市场预计在预测期内(2023-2030)每年将以 5.0% 左右的CAGR成长

由于製造商从处方分销管道转向非处方药,非处方药市场预计将以显着的速度成长

根据类型,预计感冒和咳嗽细分市场将在 2022 年呈现最大市场份额

根据配销通路,药局和零售药局是 2022 年的领先细分市场

按地区划分,北美是 2022 年的主要收入来源

非处方药市场-細項分析:

全球非处方药市场根据类型、配销通路和地区进行细分。

根据类型,市场可分为镇痛药、感冒和咳嗽药物、消化和肠道药物、皮肤治疗、维生素和矿物质等。由于季节性变化,人们中普通感冒和咳嗽的发生率不断增加,预计感冒和咳嗽药物领域将主导市场。据美国疾病管制与预防中心称,感冒和咳嗽是 10 岁以下儿童和 65 岁以上老年人群中最常见的病症,这导致对治疗产品的需求不断增加。

根据配销通路,市场分为药局和零售药房、医院药房和网路药房。由于提供非处方药产品的零售药局数量不断增加,以及患者对商店和零售药局这些产品的偏好不断增加,预计药局和零售药局部门在预测期内将占据最大的市场份额。由于非处方药分销管道的增加和不同产品的供应,医院药房部门占据了第二大市场份额。

非处方药市场 - 地理洞察

从地理来看,该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

非处方药市场-竞争格局:

在竞争激烈的非处方药领域,製药公司不断创新,以扩大其产品组合併提高消费者的可及性。强生、拜耳和赛诺菲等主要企业正在策略性地从处方药转向非处方药,从而增加全球针对各种健康状况的自我保健药物的供应。此外,由于线上销售的增加以及自有品牌製造商和电子商务巨头之间的合作伙伴关係的推动,自有品牌非处方药产品的激增是一个新兴趋势。这一趋势正在使市场格局多样化,并为消费者提供更广泛的自我药疗选择。最近的合作和产品发布,例如MCKESSON CORPORATION 推出Foster & Thrive 品牌,以及RL Limited 与AFT Pharmaceuticals 合作进行线上OTC 销售,反映了该行业致力于满足不断变化的患者需求并利用对无障碍医疗解决方案不断增长的需求。

最近的发展:

2023 年 6 月,多元化製药公司 MCKESSON CORPORATION 宣布推出 Foster & Thrive,这是一个精心策划的 OTC 健康和保健产品自有品牌,以满足不断变化的患者需求和不断增长的需求。

2022 年 7 月,电子商务和数位行销公司 RL Limited 与纽西兰公司 AFT Pharmaceuticals 合作,透过线上市场天猫国际推出一系列 OTC 分销管道。

目录

第一章:非处方药市场概述

  • 研究范围
  • 市场预估年份

第 2 章:执行摘要

  • 市场片段
    • 非处方药市场摘要(按类型)
    • 按配销通路分類的非处方药市场摘要
    • 按国家/地区分類的非处方药市场摘要
    • 按地区分類的非处方药市场摘要
  • 竞争洞察

第 3 章:非处方药主要市场趋势

  • 非处方药市场驱动因素
    • 市场驱动因素的影响分析
  • 非处方药市场限制
    • 市场限制影响分析
  • 非处方药市场机会
  • 非处方药市场未来趋势

第 4 章:OTC 药品产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章:OTC 药品市场:COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章:非处方药市场格局

  • 2022 年非处方药市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章:非处方药市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 止痛药
    • 感冒和咳嗽的补救措施
    • 消化和肠道疗法
    • 皮肤治疗
    • 维生素和矿物质
    • 其他的

第 8 章:非处方药市场 - 按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 药局和零售药局
    • 医院药房
    • 网路药局

第 9 章:非处方药市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美非处方药主要製造商
    • 北美市场规模和预测(按国家)
    • 北美市场规模和预测(按类型)
    • 北美市场规模和预测(按配销通路)
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲非处方药主要製造商
    • 欧洲市场规模和预测(按国家)
    • 欧洲市场规模与预测(按类型)
    • 欧洲市场规模和预测(按配销通路)
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区非处方药主要製造商
    • 亚太地区市场规模与预测(按国家)
    • 亚太地区市场规模与预测(按类型)
    • 亚太地区市场规模和预测(按配销通路)
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲非处方药主要製造商
    • 拉丁美洲市场规模与预测(按国家)
    • 拉丁美洲市场规模与预测(按类型)
    • 拉丁美洲市场规模和预测(按配销通路)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲非处方药主要製造商
    • 中东和非洲市场规模及预测(按国家)
    • 中东和非洲市场规模及预测(按类型)
    • 中东和非洲市场规模及预测(按配销通路)
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章:主要供应商分析 - OTC 药品产业

  • 竞争仪表板
  • 公司简介
    • Johnson & Johnson Services Inc.
    • Bayer AG
    • Novartis AG
    • Sanofi SA
    • Pfizer
    • GlaxoSmithKline
    • Boehringer Ingelheim International GmbH
    • Reckitt Benckiser Group PLC
    • Takeda Pharmaceutical Company Ltd.
    • Perrigo Company plc

第 11 章:360 度分析师视角

第 12 章:附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1980

REPORT HIGHLIGHT

OTC Drugs Market size was valued at USD 162,794.3 Million in 2022, expanding at a CAGR of 5.0% from 2023 to 2030.

OTC or over the counter Distribution channels are pharmaceutical products that are considered safe to buy without the requirement of a prescription from a medical professional. These products are available in hospital pharmacies, medical stores, and sometimes even grocery shops, and are sold legally without any prescription. OTC medicines are used to treat some common symptoms, which include the common cold, body pain, allergies and flu, heartburn, acne, and other basic health problems.

OTC Drugs Market- Market Dynamics

The shift of manufacturers from prescription Distribution channels to OTC is expected to propel the market demand

One of the prominent trends in the market is the shift of manufacturers from prescription Distribution channels to OTC. Many manufacturing companies are switching their products from prescription to OTC. For instance, Bayer AG states in their 2019 annual report that, as part of its strategy, the company will change some of its prescriptive products suitable for self-care to OTC. This is anticipated to lead to a higher availability of these Distribution channels for various disease conditions in emerging and developed countries. Other trends in the market include the increasing number of private-label OTC products. The rise in online sales of the OTC products and tie-ups between private label manufacturers and e-commerce companies are developing new trends in the market. For instance, In September 2019, Dr. Reddy's Laboratories Ltd. announced the launch of an OTC Omeprazole Delayed-Release tablet in the U.S. market. These upcoming new trends will diversify market growth during the forecast period.

OTC Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global OTC Drugs Market is estimated to grow annually at a CAGR of around 5.0% over the forecast period (2023-2030)

The OTC Drugs Market is projected to grow at a significant rate driven by shift of manufacturers from prescription Distribution channels to OTC

Based on Type, the cold & cough segment was predicted to show maximum market share in the year 2022

Based on Distribution channel, drug stores & retail pharmacies was the leading Segment in 2022

On the basis of region, North America was the leading revenue generator in 2022

OTC Drugs Market- Segmentation Analysis:

The Global OTC Drugs Market is segmented on the basis of Type, By Distribution channel, and Region.

On the basis of type, the market can be segmented into analgesics, cold & cough remedies, digestives & intestinal remedies, skin treatment, vitamins & minerals, and others. The cold & cough remedies segment is anticipated to dominate the market owing to the increasing occurrence of common colds and coughs among the population due to seasonal variation. According to the Centers for Disease Control and Prevention, cold and cough are the most common conditions in children below the age of 10 years and in geriatric populations above 65 years, which is leading to an increasing demand for therapeutic products.

Based on distribution channel, the market is segmented into drug stores & retail pharmacies, hospital pharmacies, and online pharmacies. The drug stores & retail pharmacies segment is projected to account for the largest market share during the forecast period owing to the increasing number of retail pharmacies offering OTC products and the rising patient preference for stores & retail pharmacies for these products. The hospital pharmacies segment accounts for the second-largest market share owing to increasing access to OTC Distribution channels and the availability of different products.

OTC Drugs Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

OTC Drugs Market- Competitive Landscape:

In the highly competitive OTC drug space, pharmaceutical companies are continually innovating to expand their product portfolios and enhance consumer access. Major players like Johnson & Johnson, Bayer AG, and Sanofi are strategically shifting from prescription drugs to over-the-counter offerings, thereby increasing the availability of self-care medications for various health conditions globally. Additionally, an emerging trend is the proliferation of private-label OTC products, driven by increasing online sales and partnerships between private label manufacturers and e-commerce giants. This trend is diversifying the market landscape and offering consumers a wider array of choices for self-medication. Recent collaborations and product launches, such as MCKESSON CORPORATION's introduction of the Foster & Thrive brand and RL Limited's partnership with AFT Pharmaceuticals for online OTC sales, reflect the industry's commitment to meeting evolving patient needs and capitalizing on the growing demand for accessible healthcare solutions.

Recent Developments:

In June 2023, MCKESSON CORPORATION, a diversified pharmaceutical company announced the launch of Foster & Thrive, a curated private brand of OTC health and wellness products in order to meet evolving patient needs and growing demand.

In July 2022, RL Limited, an e-commerce and digital marketing company, teamed up with AFT Pharmaceuticals, a New Zealand-based company, to launch a range of OTC Distribution channels through the online marketplace Tmall Global.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL OTC DRUGS MARKET KEY PLAYERS

  • Johnson & Johnson Services Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A
  • Pfizer
  • GlaxoSmithKline
  • Boehringer Ingelheim International GmbH
  • Reckitt Benckiser Group PLC
  • Takeda Pharmaceutical Company Ltd.
  • Perrigo Company plc

GLOBAL OTC DRUGS MARKET, BY TYPE

  • Analgesics
  • Cold & Cough Remedies
  • Digestives & Intestinal Remedies
  • Skin Treatment
  • Vitamins & Minerals
  • Others

GLOBAL OTC DRUGS MARKET, BY DISTRIBUTION CHANNEL

  • Drug stores & retail pharmacies
  • Hospital pharmacies
  • Online pharmacies

GLOBAL OTC DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. OTC Drug Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. OTC Drug Market Snippet by Type
    • 2.1.2. OTC Drug Market Snippet by Distribution Channel
    • 2.1.3. OTC Drug Market Snippet by Country
    • 2.1.4. OTC Drug Market Snippet by Region
  • 2.2. Competitive Insights

3. OTC Drug Key Market Trends

  • 3.1. OTC Drug Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. OTC Drug Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. OTC Drug Market Opportunities
  • 3.4. OTC Drug Market Future Trends

4. OTC Drug Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. OTC Drug Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. OTC Drug Market Landscape

  • 6.1. OTC Drug Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. OTC Drug Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Analgesics
    • 7.1.3. Cold & Cough Remedies
    • 7.1.4. Digestives & Intestinal Remedies
    • 7.1.5. Skin Treatment
    • 7.1.6. Vitamins & Minerals
    • 7.1.7. Others

8. OTC Drug Market - By Distribution Channel

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 8.1.2. Drug stores & retail pharmacies
    • 8.1.3. Hospital pharmacies
    • 8.1.4. Online pharmacies

9. OTC Drug Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. OTC Drug Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. OTC Drug Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. OTC Drug Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. OTC Drug Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. OTC Drug Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- OTC Drug Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Johnson & Johnson Services Inc.
    • 10.2.2. Bayer AG
    • 10.2.3. Novartis AG
    • 10.2.4. Sanofi S.A
    • 10.2.5. Pfizer
    • 10.2.6. GlaxoSmithKline
    • 10.2.7. Boehringer Ingelheim International GmbH
    • 10.2.8. Reckitt Benckiser Group PLC
    • 10.2.9. Takeda Pharmaceutical Company Ltd.
    • 10.2.10. Perrigo Company plc

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE OTC Drug Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global OTC Drug Market, by Type 2018-2030 (USD Million)
  • TABLE OTC Drug Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global OTC Drug Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE OTC Drug Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global OTC Drug Market, by Region 2018-2030 (USD Million)
  • TABLE North America OTC Drug Market, by Country, 2018-2030 (USD Million)
  • TABLE North America OTC Drug Market, by Type, 2018-2030 (USD Million)
  • TABLE North America OTC Drug Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe OTC Drug Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe OTC Drug Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe OTC Drug Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific OTC Drug Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific OTC Drug Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific OTC Drug Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America OTC Drug Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America OTC Drug Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America OTC Drug Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa OTC Drug Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa OTC Drug Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa OTC Drug Market, by Distribution Channel, 2018-2030 (USD Million)